Fig. 4
Establishment and verification of the prognostic signature of the ERS-related lncRNA signature in the training, validation and complete sets. (A-C) Kaplan–Meier survival curves of LSCC patients’ OS in the high-risk and low-risk groups in the training (A), validation (B), and complete sets (C); (D-F) Risk score distribution in the high-risk and low-risk groups in the training (D), validation (E), and complete sets (F); (G–I) Scatter plots of LSCC patient survival status distribution in the training (G), validation (H), and complete sets (I); (J–L) Risk heatmaps of the 3 ERS-related lncRNA expression in the training (J), validation (K), and complete sets (L); (M–O) ROC curves of the prognostic ERS-related lncRNAs signature at 1-, 2-, and 3-year in the training (M), validation (N) and complete sets (O); (P-R) AUC of ROC curves comparing the prognostic accuracy of the risk score and other prognostic factors in the training (P), validation (Q) and complete sets (R).
